Is Theravance Biopharma, Inc. technically bullish or bearish?
As of September 19, 2025, Theravance Biopharma, Inc. shows a mildly bullish trend with positive MACD and KST indicators, despite a bearish RSI and mixed Dow Theory signals, having returned 3.20% over the past month while outperforming the S&P 500 year-to-date with a 47.50% return.
As of 19 September 2025, the technical trend for Theravance Biopharma, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the RSI is bearish on both weekly and monthly time frames. The Bollinger Bands indicate a mildly bullish stance, and moving averages are bullish on a daily basis. However, Dow Theory presents a mixed view with a mildly bearish weekly signal and a mildly bullish monthly signal. In terms of performance, the stock has returned 3.20% over the past month, underperforming the S&P 500's 3.95%, but it has significantly outperformed the index year-to-date with a return of 47.50% compared to the S&P 500's 13.31%. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and KST indicators, despite the bearish RSI and mixed Dow Theory signals.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
